» Articles » PMID: 23533920

Therapeutic Potential of Umbilical Cord Mesenchymal Stromal Cells Transplantation for Cerebral Palsy: a Case Report

Overview
Publisher Wiley
Specialty General Surgery
Date 2013 Mar 28
PMID 23533920
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Cerebral palsy is the most common motor disability in childhood. In current paper, we first report our clinical data regarding administration of umbilical cord mesenchymal stem cells (MSCs) transplantation in treatment of cerebral palsy. A 5-year-old girl with cerebral palsy was treated with multiple times of intravenous and intrathecal administration of MSCs derived from her young sister and was followed up for 28 months. The gross motor dysfunction was improved. Other benefits included enhanced immunity, increased physical strength, and adjusted speech and comprehension. Temporary low-grade fever was the only side effect during the treatment. MSCs may be a safe and effective therapy to improve symptoms in children with cerebral palsy.

Citing Articles

A systematic review of cell therapy modalities and outcomes in cerebral palsy.

Akat A, Karaoz E Mol Cell Biochem. 2024; 480(2):891-922.

PMID: 39033213 DOI: 10.1007/s11010-024-05072-3.


Allogeneic mesenchymal stem cells may be a viable treatment modality in cerebral palsy.

Boyali O, Kabatas S, Civelek E, Ozdemir O, Bahar-Ozdemir Y, Kaplan N World J Clin Cases. 2024; 12(9):1585-1596.

PMID: 38576742 PMC: 10989435. DOI: 10.12998/wjcc.v12.i9.1585.


Are We Getting It Right? A Scoping Review of Outcomes Reported in Cell Therapy Clinical Studies for Cerebral Palsy.

Finch-Edmondson M, Paton M, Honan I, Karlsson P, Stephenson C, Chiu D J Clin Med. 2022; 11(24).

PMID: 36555936 PMC: 9786692. DOI: 10.3390/jcm11247319.


Advanced Medical Therapies in the Management of Non-Scarring Alopecia: Areata and Androgenic Alopecia.

Martinez-Lopez A, Montero-Vilchez T, Sierra-Sanchez A, Molina-Leyva A, Arias-Santiago S Int J Mol Sci. 2020; 21(21).

PMID: 33182308 PMC: 7664905. DOI: 10.3390/ijms21218390.


Therapeutic evidence of umbilical cord-derived mesenchymal stem cell transplantation for cerebral palsy: a randomized, controlled trial.

Gu J, Huang L, Zhang C, Wang Y, Zhang R, Tu Z Stem Cell Res Ther. 2020; 11(1):43.

PMID: 32014055 PMC: 6998370. DOI: 10.1186/s13287-019-1545-x.


References
1.
Bae K, Park J, Kim H, Kim D, Park D, Kang S . Neuron-like differentiation of bone marrow-derived mesenchymal stem cells. Yonsei Med J. 2011; 52(3):401-12. PMC: 3101055. DOI: 10.3349/ymj.2011.52.3.401. View

2.
Shevell M . Current understandings and challenges in the management of cerebral palsy. Minerva Pediatr. 2009; 61(4):399-413. View

3.
Goldstein M . The treatment of cerebral palsy: What we know, what we don't know. J Pediatr. 2004; 145(2 Suppl):S42-6. DOI: 10.1016/j.jpeds.2004.05.022. View

4.
Titomanlio L, Kavelaars A, Dalous J, Mani S, El Ghouzzi V, Heijnen C . Stem cell therapy for neonatal brain injury: perspectives and challenges. Ann Neurol. 2011; 70(5):698-712. DOI: 10.1002/ana.22518. View

5.
Bax M, Goldstein M, Rosenbaum P, Leviton A, Paneth N, Dan B . Proposed definition and classification of cerebral palsy, April 2005. Dev Med Child Neurol. 2005; 47(8):571-6. DOI: 10.1017/s001216220500112x. View